Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 17, 2008
J Am Soc Nephrol 20: 645-654, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008060590

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008060590v1
20/3/645    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Locatelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Locatelli, F.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH

Effect of Membrane Permeability on Survival of Hemodialysis Patients

Francesco Locatelli*, Alejandro Martin-Malo{dagger}, Thierry Hannedouche{ddagger}, Alfredo Loureiro§, Menelaos Papadimitriou||, Volker Wizemann, Stefan H. Jacobson**, Stanislaw Czekalski{dagger}{dagger}, Claudio Ronco{ddagger}{ddagger}, Raymond Vanholder§§ for the Membrane Permeability Outcome (MPO) Study Group

* Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Lecco, Italy; {dagger} Department of Nephrology, University Hospital Reina Sofia, Cordoba, Spain; {ddagger} Department of Nephrology, University Hospital, Strasbourg, France; § Department of Nephrology, Portuguese Institute of Oncology, Porto, Portugal; || Department of Nephrology, Hippokration General Hospital, Thessaloniki Greece; Georg-Haas-Dialysis Centre, Giessen, Germany; ** Department of Nephrology, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden; {dagger}{dagger} Department of Nephrology, Transplantology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland; {ddagger}{ddagger} Department of Nephrology and Intensive Care, St. Bortolo Hospital, Vincenza, Italy; and §§ Department of Internal Medicine, Nephrology Section, University Hospital, Ghent, Belgium

Correspondence: Prof. Francesco Locatelli, Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Via dell'Eremo 9/11, I-23900 Lecco, Italy. Phone: +39-0341-489850; Fax: +39-0341-489860; E-mail: f.locatelli{at}ospedale.lecco.it

Received for publication June 10, 2008. Accepted for publication September 22, 2008.

The effect of high-flux hemodialysis membranes on patient survival has not been unequivocally determined. In this prospective, randomized clinical trial, we enrolled 738 incident hemodialysis patients, stratified them by serum albumin ≤4 and >4 g/dl, and assigned them to either low-flux or high-flux membranes. We followed patients for 3 to 7.5 yr. Kaplan-Meier survival analysis showed no significant difference between high-flux and low-flux membranes, and a Cox proportional hazards model concurred. Patients with serum albumin ≤4 g/dl had significantly higher survival rates in the high-flux group compared with the low-flux group (P = 0.032). In addition, a secondary analysis revealed that high-flux membranes may significantly improve survival of patients with diabetes. Among those with serum albumin ≤4 g/dl, slightly different effects among patients with and without diabetes suggested a potential interaction between diabetes status and low serum albumin in the reduction of risk conferred by high-flux membranes. In summary, we did not detect a significant survival benefit with either high-flux or low-flux membranes in the population overall, but the use of high-flux membranes conferred a significant survival benefit among patients with serum albumin ≤4 g/dl. The apparent survival benefit among patients who have diabetes and are treated with high-flux membranes requires confirmation given the post hoc nature of our analysis.


Related Articles

Effect of Membrane Permeability on Survival of Hemodialysis Patients
Alfred K. Cheung and Tom Greene
J. Am. Soc. Nephrol. 2009 20: 462-464. [Full Text] [PDF]

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A12. [Full Text] [PDF]



This article has been cited by other articles:


Home page
NDT PlusHome page
I. Ledebo and P. J. Blankestijn
Haemodiafiltration--optimal efficiency and safety
NDT Plus, February 1, 2010; 3(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. L. Penne, N. C. van der Weerd, P. J. Blankestijn, M. A. van den Dorpel, M. P.C. Grooteman, M. J. Nube, P. M. ter Wee, R. Levesque, M. L. Bots, and on behalf of the CONTRAST investigators
Role of Residual Kidney Function and Convective Volume on Change in {beta}2-Microglobulin Levels in Hemodiafiltration Patients
Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(1): 80 - 86.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Tattersall, B. Canaud, O. Heimburger, L. Pedrini, D. Schneditz, W. Van Biesen, and European Renal Best Practice advisory Board
High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study
Nephrol. Dial. Transplant., December 22, 2009; (2009) gfp626v1.
[Full Text] [PDF]


Home page
CJASNHome page
E. Vilar, A. C. Fry, D. Wellsted, J. E. Tattersall, R. N. Greenwood, and K. Farrington
Long-Term Outcomes in Online Hemodiafiltration and High-Flux Hemodialysis: A Comparative Analysis
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(12): 1944 - 1953.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. Lameire, W. Van Biesen, and R. Vanholder
Did 20 Years of Technological Innovations in Hemodialysis Contribute to Better Patient Outcomes?
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S30 - S40.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
R. Vanholder, D. Abramowicz, J. B. Cannata-Andia, V. Cocchi, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, S. Jenkins, et al.
The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP)
NDT Plus, June 1, 2009; 2(3): 213 - 221.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. K. Cheung and T. Greene
Effect of Membrane Permeability on Survival of Hemodialysis Patients
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 462 - 464.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP